» Articles » PMID: 25882914

Generation and Evaluation of a Recombinant Genotype VII Newcastle Disease Virus Expressing VP3 Protein of Goose Parvovirus As a Bivalent Vaccine in Goslings

Overview
Journal Virus Res
Specialty Microbiology
Date 2015 Apr 18
PMID 25882914
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Newcastle disease virus (NDV) and Goose parvovirus (GPV) are considered to be two of the most important and widespread viruses infecting geese. In this study, we generated a recombinant rmNA-VP3, expressing GPV VP3 using a modified goose-origin NDV NA-1 by changing the multi-basic cleavage site motif RRQKR↓F of the F protein to the dibasic motif GRQGR↓L as that of the avirulent strain LaSota as a vaccine vector. Expression of the VP3 protein in rmNA-VP3 infected cells was detected by immunofluorescence and Western blot assay. The genetic stability was examined by serially passaging 10 times in 10-day-old embryonated SPF chicken eggs. Goslings were inoculated with rmNA-VP3 showed no apparent signs of disease and developed a strong GPV and NDV neutralizing antibodies response. This is the first study demonstrating that recombinant NDV has the potential to serve as bivalent live vaccine against Goose parvovirus and Newcastle disease virus infection in birds.

Citing Articles

Development of a Novel Chimeric ND-GP cVLPs Vaccine for the Prevention of Goose-Derived Newcastle Disease and Gosling Plague.

Li J, Ding J, Guo C, Xu X, Shan C, Qian J Microorganisms. 2024; 12(11).

PMID: 39597655 PMC: 11596917. DOI: 10.3390/microorganisms12112266.


The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy.

Yang H, Tian J, Zhao J, Zhao Y, Zhang G Viruses. 2024; 16(6).

PMID: 38932177 PMC: 11209082. DOI: 10.3390/v16060886.


Negative-Strand RNA Virus-Vectored Vaccines.

Murr M, Mettenleiter T Methods Mol Biol. 2024; 2786:51-87.

PMID: 38814390 DOI: 10.1007/978-1-0716-3770-8_3.


Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use.

Fulber J, Kamen A Viruses. 2022; 14(5).

PMID: 35632717 PMC: 9143368. DOI: 10.3390/v14050975.


Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human.

Vilela J, Rohaim M, Munir M Vaccines (Basel). 2022; 10(2).

PMID: 35214716 PMC: 8876055. DOI: 10.3390/vaccines10020259.


References
1.
Huang Z, Elankumaran S, Panda A, Samal S . Recombinant Newcastle disease virus as a vaccine vector. Poult Sci. 2003; 82(6):899-906. DOI: 10.1093/ps/82.6.899. View

2.
Ge J, Wang X, Tian M, Wen Z, Feng Q, Qi X . Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease. Vaccine. 2014; 32(13):1514-21. DOI: 10.1016/j.vaccine.2014.01.020. View

3.
Jansson D, Feinstein R, Kardi V, Mato T, Palya V . Epidemiologic investigation of an outbreak of goose parvovirus infection in Sweden. Avian Dis. 2007; 51(2):609-13. DOI: 10.1637/0005-2086(2007)51[609:EIOAOO]2.0.CO;2. View

4.
Gough R, Spackman D . Studies with a duck embryo adapted goose parvovirus vaccine. Avian Pathol. 1982; 11(3):503-10. DOI: 10.1080/03079458208436121. View

5.
Alexander D . Newcastle disease and other avian paramyxoviruses. Rev Sci Tech. 2000; 19(2):443-62. DOI: 10.20506/rst.19.2.1231. View